Corporate Updates

Dr Reddy’s CPS facility clears USFDA audit

Views: 1.0K

Dr Reddy’s Laboratories has received establishment inspection report (EIR) from the US health regulator for a unit of its Srikakulam plant in Andhra Pradesh.

“The company has received EIR from the United States Food and Drug Administration (USFDA) for its formulations manufacturing facility at Srikakulam unit II,” Dr Reddy’s said in a filing to BSE.

The audit of the facility has been completed today with zero observations, the drug firm said.

The Custom Pharmaceutical Services (CPS) facility of Dr Reddy’s Laboratories Ltd at its Technology Development Centre (TDC-1), Miyapur has cleared the USFDA audit.

Most Popular





Get Heard Portal


eHealth Event Report




About Us

eHEALTH, as an online and print platform, elegantly guides the healthcare stakeholders through the trajectory of healthcare that witnesses fascinating changes on a daily basis due to increased technological intervention and other structural changes to create a ‘community of practice’ of healthcare stakeholders.


Contact Us

Elets Technomedia Pvt. Ltd.
Stellar IT Park, Office No. 7A/7B, 5th Floor, Tower -2 Annexe Building, C-25, Sector 62 Noida, Uttar Pradesh - 201309, India

Copyright © 2018 Elets | All rights reserved

To Top